Please select the option that best describes you:
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
The study showed no benefit in terms of cancer control or toxicity. There was a significant finding of worse sexual function, but this was deemed to be not clinically significant. How should we approach patients interested in discussing proton therapy for their localized prostate cancer?
Answer from: Radiation Oncologist at Academic Institution
PARTIQoL was a randomized study of proton vs. photon beam therapy (PBT) for low-intermediate risk prostate cancer (T1-T2c N0 M0, ≤GG3, PSA < 20). Patients were treated with RT alone without ADT. Treatment volumes included the prostate to a full dose, the bilateral SVs to a prophylactic dose, a...
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
Thank you for the comprehensive answer Dr. @Patel!
It is interesting you talk about integral dose - that almost rarely comes up from the patient in my experience. They have read and have been told that it IS less toxic (not that it may be). They are told that protons are better and the authorizatio...
Comments
Radiation Oncologist at Northeast Alabama Regional Medical Center
I don't know what much to make of this study. The ...
I don't know what much to make of this study. The ...